Pancreatic Ductal Adenocarcinoma (PDAC) trials recruiting in Florida
All Pancreatic Ductal Adenocarcinoma (PDAC) trials nationally
9
Recruiting in Florida
7
Cities with sites
Cities in Florida
Tampa 6Sarasota 4Jacksonville 2Celebration 1Port Saint Lucie 1St. Petersburg 1West Palm Beach 1
Recruiting trials in Florida
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )